![John Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Doyle
Financieel Directeur/CFO bij
COGNITION THERAPEUTICS, INC.
Vermogen: 730 352 $ op 31-05-2026
Profiel
John Doyle is Chief Financial & Accounting Officer at Cognition Therapeutics, Inc. since 2023.
Former roles include Chief Financial Officer at 4D Pharma Plc from 2022 to 2023, Chief Financial Officer, Treasurer & Senior VP at Chiasma, Inc. in 2021, Vice President-Finance & Investor Relations at Verastem, Inc. from 2019 to 2020, Head-Financial Planning & Analysis at SimpliVity Corp.
from 2016 to 2018, Director-Business Unit Financial Planning at PAREXEL International Corp.
from 2015 to 2016.
Education includes undergraduate studies at the University of Massachusetts.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-05-2026 | 618.942 ( 0,69% ) | 730 352 $ | 31-05-2026 |
Actieve functies van John Doyle
| Bedrijven | Functie | Begin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-05-2023 |
Eerdere bekende functies van John Doyle
| Bedrijven | Functie | Einde |
|---|---|---|
| 4D PHARMA PLC | Financieel Directeur/CFO | 30-03-2023 |
| CHIASMA, INC. | Financieel Directeur/CFO | 05-08-2021 |
| VERASTEM, INC. | Investor Relations Contact | 01-12-2020 |
SimpliVity Corp.
 SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Corporate Officer/Principal | 01-02-2018 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01-04-2016 |
Opleiding van John Doyle
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
 Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
SimpliVity Corp.
SimpliVity Corp. Information Technology ServicesTechnology Services Provides hyperconverged infrastructure that accelerates the deployment of resources and workloads | Technology Services |
4D Pharma Plc
 4D Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which engages in the development of live bio therapeutics | Health Technology |
